Our role-based focus

 

 

 

Each functional area in a MedTech company requires specific types of data, used to perform different types of analysis, and then generates function-specific reports (like a Clinical Evaluation Report, for example).
We have conducted extensive research with MedTech companies to better understand the needs of each of those areas. Our system is designed around the needs of each of these roles, to help them get their job done faster.
This is how we help those in the role of;

Investor and VC

De-Risk your MedTech Investments with FDA and Medicare Data

As an investor, you need solid data to revalidate MedTech firms pitch data  before investing. MedTech Tracker provides unbiased insights on market size, reimbursement, and regulatory risk.

Investing in MedTech firms comes with regulatory, market, and reimbursement risks. With so many investment requests, it can be difficult to identify which firms have real potential and which ones are overpromising. MedTech Tracker provides the unbiased insights you need to make data-driven investment decisions and reduce risk.

MedTech Roles with airport park concept

Click to enlarge

Your Challenges

  • Too Many Investment Requests: Filtering through countless MedTech pitches with limited transparency.

  • Hard to Assess Firm Potential: Differentiating strong business models from Medtech firm claims.

  • Uncertain Market & Regulatory Risks: Need real data on FDA approvals, reimbursements, and competitive positioning.

How MedTech Tracker Helps

  • Unbiased Market Size & Growth Analysis: Understand realistic market potential beyond founder optimism.

  • Reality Check on Firm Claims: Validate clinical, regulatory, and reimbursement data before investing.

    How to get started

    Download free PDF samples

    Clinical trial document for the treatment of breast cancer

    Clinical Trial PDF

    This is a sample of the IRB protocol document titled ”Immunotherapy for the treatment of breast cancer” by;

    Memorial Sloan-Kettering Cancer Centre

    Reimbursement Analysis

    Reimbursement Analysis for Open data

    This excel file contains information from Medicare’s Open Payments datasets. Specific to payer ID 100000005601. It includes general payments or other transfers of value and Information about physicians who hold an ownership or investment interest in an applicable manufacturer or applicable GPO or who have an immediate family member holding such interest.

    510k for medical device

    510k PDF

    This is a sample of the 510(k) premarket notification of intent to market the device named Attune division knee system by DePuy Ireland UC.

    This file contains information from Medicare's Provider Summary dataset and is limited to HCPCS code 22853. The data includes Medicare Physician and Other Practitioners by Geography and Service dataset containing information on use, payments, submitted charges, and beneficiary demographic and health characteristics organized by geography, Healthcare Common Procedure Coding System (HCPCS) code, submitted charges organized by National Provider Identifier (NPI), and place of service.

    Reimbursement Analysis for HCPCS Data

     This excel file contains HCPCS data including Medicare Physician and  Other Practitioners by Geography and Service dataset containing information on use, payments, submitted charges, and beneficiary demographic, health characteristics, National Provider Identifier (NPI), and place of service.

    Over 200,000+ PDFs available. Still Can’t Find What You’re Looking For?

    MedTech Reference Guide

    MedTech Reference Guide

    Gain a better understanding of your product code, access essential medicare data and reimbursement codes. Download the MedTech Reference Guide today and request your free Regulatory and Reimbursement Report to stay ahead in the industry.

    "Investors want real market opportunities, not just optimistic claims. Founders need to show realistic market size, the competitor landscape, and reimbursement insights on who's paying, how much, and whether the product is financially viable."

    Kelly Carrol

    Investor

    Spark Western Switzerland